| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.552 | 25.052 | 28.672 | 28.816 | 33.599 | 42.880 | 51.502 | 46.435 | 44.981 |
| Total Income - EUR | - | 20.552 | 25.052 | 28.672 | 28.816 | 33.599 | 42.880 | 51.502 | 46.435 | 44.981 |
| Total Expenses - EUR | - | 12.449 | 16.205 | 13.596 | 6.909 | 922 | 246 | 171 | 7.790 | 14.893 |
| Gross Profit/Loss - EUR | - | 8.103 | 8.848 | 15.077 | 21.907 | 32.677 | 42.634 | 51.331 | 38.645 | 30.088 |
| Net Profit/Loss - EUR | - | 7.487 | 8.096 | 14.217 | 21.043 | 31.737 | 41.502 | 50.243 | 38.250 | 29.706 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Csibi T & M Biolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 8.097 | 8.366 | 17.719 | 24.469 | 32.200 | 41.970 | 50.773 | 40.094 | 32.223 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 11 | 11 | 10 | 15.594 | 21.294 | 28.705 | 36.762 | 27.903 | 22.186 |
| Cash | - | 8.086 | 8.356 | 17.709 | 8.875 | 10.906 | 13.265 | 14.011 | 12.191 | 10.037 |
| Shareholders Funds | - | 7.531 | 8.149 | 17.466 | 24.271 | 31.870 | 41.736 | 50.742 | 38.904 | 30.598 |
| Social Capital | - | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 636 | 217 | 253 | 198 | 331 | 234 | 31 | 1.190 | 1.625 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Csibi T & M Biolife Srl